Clinical Trial

Early Use of Airway Pressure Release Ventilation (APRV) in ARDS

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
Airway pressure release ventilation (APRV) is a time-cycled, pressure controlled, intermittent mandatory ventilation mode with extreme inverse I:E ratios. Currently it is considered as a non-conventional ventilatory mode. The investigators aim to compare APRV with conventional mechanical ventilation (MV) in patients with acute respiratory distress syndrome (ARDS).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-01-06; most recent amendment 2025-03-15.
Trial Details
NCT Number NCT04221737
Lead Sponsor Hospital Civil de Guadalajara
Conditions Acute Respiratory Distress Syndrome
Enrollment 150 participants
Start Date 2017-07-15
Primary Completion 2025-11 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-19